Extended Results and Independent Validation of a Phase 2 Trial of Metastasis-Directed Therapy for Molecularly Defined Oligometastatic Prostate Cancer-Reference-Cited by-同舟云学术

Extended Results and Independent Validation of a Phase 2 Trial of Metastasis-Directed Therapy for Molecularly Defined Oligometastatic Prostate Cancer

Published:2022-11 Issue:4 Volume:114 Page:693-704
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Glicksman Rachel M.^ORCID,Ramotar Matthew,Metser Ur,Chung Peter W.,Liu Zhihui,Vines Douglass,Finelli Antonio,Hamilton Robert,Fleshner Neil E.,Perlis Nathan,Zlotta Alexandre R.,Bayley Andrew,Helou Joelle,Raman Srinivas,Kulkarni Girish,Catton Charles,Lam Tony,Chan Rosanna,Warde Padraig,Gospodarowicz Mary,Jaffray David A.,Berlin Alejandro

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference23 articles.

1. Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence: A prospective, randomized, multicenter phase II trial;Ost;J Clin Oncol,2018

2. Outcomes of observation vs stereotactic ablative radiation for oligometastatic prostate cancer: The oriole phase 2 randomized clinical trial;Phillips;JAMA Oncol,2020

3. Curative-intent metastasis-directed therapies for molecularly-defined oligorecurrent prostate cancer: A prospective phase ii trial testing the oligometastasis hypothesis;Glicksman;Eur Urol,2021

4. [(18)f]dcfpyl pet-mri/ct for unveiling a molecularly defined oligorecurrent prostate cancer state amenable for curative-intent ablative therapy: Study protocol for a phase ii trial;Glicksman;BMJ Open,2020

5. Rationale of technical requirements for NRG-BR001: The first NCI-sponsored trial of sbrt for the treatment of multiple metastases;Al-Hallaq;Pract Radiat Oncol,2016

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recommendations on the treatment of metastatic hormone-sensitive prostate cancer: Patient selection;Actas Urológicas Españolas (English Edition);2024-05

2. Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part III: Salvage Therapy After Radiotherapy or Focal Therapy, Pelvic Nodal Recurrence and Oligometastasis, and Future Directions;Journal of Urology;2024-04

3. Multi-institutional Analysis of Metastasis-directed Therapy with or Without Androgen Deprivation Therapy in Oligometastatic Castration-sensitive Prostate Cancer;European Urology Oncology;2024-04

4. Recomendaciones de tratamiento en el cáncer de próstata hormonosensible metastásico: selección de pacientes;Actas Urológicas Españolas;2024-04

5. Metastasis-directed therapy in oligometastatic prostate cancer;Current Opinion in Urology;2024-03-05